Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 33.99% is in line with its 5-year average of 33.21%, around the middle of its 5-year range (30.09%–37.68%).
As of the fiscal period ended Tuesday, March 31, 2026. 2.82% below its 12-month average of 34.98%.
Reported quarterly debt to assets ratio; no daily interpolation.
DEBT TO ASSETS RATIO
33.99%
DEBT TO ASSETS RATIO AVG TTM
34.98%
DEBT TO ASSETS RATIO AVG 3Y
34.24%
DEBT TO ASSETS RATIO AVG 5Y
33.21%
DEBT TO ASSETS RATIO AVG 10Y
36.76%
DEBT TO ASSETS RATIO AVG 15Y
36.60%
DEBT TO ASSETS RATIO AVG 20Y
32.40%
CURRENT VS TTM AVG
-2.82%
CURRENT VS 3Y AVG
-0.73%
CURRENT VS 5Y AVG
+2.37%
CURRENT VS 10Y AVG
-7.53%
CURRENT VS 15Y AVG
-7.12%
CURRENT VS 20Y AVG
+4.90%
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+11621.51%
vs the sector median at left
Becton, Dickinson and Company
Market Cap
$60.26B
Debt to Assets Ratio
33.99%
TTM Avg
34.98%
3Y Avg
34.24%
5Y Avg
33.21%
Market Cap
$54.46B
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$68.46B
Debt to Assets Ratio
0.28%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$71.62B
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$48.18B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.93B
Debt to Assets Ratio
0.32%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Becton, Dickinson and Company (BDX) | $60.26B | 33.99% | 34.98% | 34.24% | 33.21% |
| Cencora, Inc. (COR)vs › | $62.18B | 0.14% | N/A | N/A | N/A |
| Cardinal Health, Inc. (CAH)vs › | $54.46B | 0.18% | N/A | N/A | N/A |
| Boston Scientific Corporation (BSX)vs › | $68.46B | 0.28% | N/A | N/A | N/A |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $71.62B | 0.07% | N/A | N/A | N/A |
| Edwards Lifesciences Corporation (EW)vs › | $48.18B | 0.05% | N/A | N/A | N/A |
| Humana Inc. (HUM)vs › | $46.67B | 0.27% | N/A | N/A | N/A |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.93B | 0.32% | N/A | N/A | N/A |
| Cigna Corporation (CI)vs › | $79.64B | 0.20% | N/A | N/A | N/A |
| IQVIA Holdings Inc. (IQV)vs › | $40.61B | 0.54% | N/A | N/A | N/A |
Debt/Assets
34.0%
Debt/Equity
0.76
Current Ratio
1.11
Interest Coverage
4.2x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-03-31 | 33.99% |
| 2025-12-31 | 35.63% |
| 2025-09-30 | 34.67% |
| 2025-06-30 | 35.23% |
| 2025-03-31 | 35.38% |
| 2024-12-31 | 34.31% |
| 2024-09-30 | 37.68% |
| 2024-06-30 | 34.76% |
| 2024-03-31 | 33.26% |
| 2023-12-31 | 30.82% |
| 2023-09-30 | 30.09% |
| 2023-06-30 | 31.65% |
| 2023-03-31 | 33.50% |
| 2022-12-31 | 30.97% |
| 2022-09-30 | 30.35% |
| 2022-06-30 | 30.76% |
| 2022-03-31 | 34.01% |
| 2021-12-31 | 32.65% |
| 2021-09-30 | 32.68% |
| 2021-06-30 | 32.64% |
| 2021-03-31 | 32.26% |
| 2020-12-31 | 32.55% |
| 2020-09-30 | 33.20% |
| 2020-06-30 | 34.69% |
| 2020-03-31 | 39.55% |
| 2019-12-31 | 37.35% |
| 2019-09-30 | 37.40% |
| 2019-06-30 | 38.64% |
| 2019-03-31 | 39.19% |
| 2018-12-31 | 39.81% |
| 2018-09-30 | 39.88% |
| 2018-06-30 | 41.22% |
| 2018-03-31 | 41.76% |
| 2017-12-31 | 41.18% |
| 2017-09-30 | 50.01% |
| 2017-06-30 | 51.17% |
| 2017-03-31 | 42.73% |
| 2016-12-31 | 45.30% |
| 2016-09-30 | 45.15% |
| 2016-06-30 | 45.79% |
| 2016-03-31 | 47.70% |
| 2015-12-31 | 49.18% |
| 2015-09-30 | 47.81% |
| 2015-06-30 | 48.64% |
| 2015-03-31 | 48.91% |
| 2014-12-31 | 54.81% |
| 2014-09-30 | 31.90% |
| 2014-06-30 | 32.11% |
| 2014-03-31 | 32.38% |
| 2013-12-31 | 32.98% |
| 2013-09-30 | 32.68% |
| 2013-06-30 | 34.26% |
| 2013-03-31 | 35.85% |
| 2012-12-31 | 35.86% |
| 2012-09-30 | 36.67% |
| 2012-06-30 | 37.84% |
| 2012-03-31 | 37.25% |
| 2011-12-31 | 36.59% |
| 2011-09-30 | 26.07% |
| 2011-06-30 | 25.65% |
| 2011-03-31 | 26.35% |
| 2010-12-31 | 27.01% |
| 2010-09-30 | 17.60% |
| 2010-06-30 | 18.77% |
| 2010-03-31 | 18.91% |
| 2009-12-31 | 18.62% |
| 2009-09-30 | 20.33% |
| 2009-06-30 | 21.35% |
| 2009-03-31 | 15.22% |
| 2008-12-31 | 15.10% |
| 2008-09-30 | 14.59% |
| 2008-06-30 | 14.26% |
| 2008-03-31 | 14.97% |
| 2007-12-31 | 15.41% |
| 2007-09-30 | 15.87% |
| 2007-06-30 | 16.27% |
| 2007-03-31 | 16.75% |
| 2006-12-31 | 17.06% |
| 2006-09-30 | 20.28% |
| 2006-06-30 | 20.33% |
| 2006-03-31 | 20.62% |
| 2005-12-31 | 21.90% |
| 2005-09-30 | 20.87% |
| 2005-06-30 | 21.81% |
| 2005-03-31 | 19.86% |
| 2004-12-31 | 19.58% |
| 2004-09-30 | 21.22% |
| 2004-06-30 | 20.20% |
| 2004-03-31 | 20.82% |
| 2003-12-31 | 20.96% |
| 2003-09-30 | 23.44% |
| 2003-06-30 | 24.86% |
| 2003-03-31 | 24.61% |
| 2002-12-31 | 24.40% |
| 2002-09-30 | 24.55% |
| 2002-06-30 | 25.46% |
